Author details

Full Name

Fredrik Wiklund

Affiliation

ORCID

Career Start Year

1994

Papers

237

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37292833	Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.	medRxiv	2023
36018819	Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.	Hum Mol Genet	2023
35637041	A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.	Eur Urol	2023
37945903	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.	Nat Genet	2023
37733366	Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.	JAMA Oncol	2023
37311464	Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.	Am J Hum Genet	2023
35152271	Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.	Prostate Cancer Prostatic Dis	2022
35971390	Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care.	International Journal of COPD	2022
36103261	Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.	Clin Cancer Res	2022
35700037	Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.	Cancer Epidemiol Biomarkers Prev	2022
35444428	Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice - A Large Population-Based Study in Sweden.	Journal of Asthma and Allergy	2022
36138404	Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes - an observational cohort study in Sweden.	BMC Cancer	2022
36201131	Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.	Pharmacoeconomics	2022
33436325	Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.	Eur Urol Oncol	2021
33473200	Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33737296	Genetically Inferred Telomere Length and Testicular Germ Cell Tumor Risk.	Cancer Epidemiol Biomarkers Prev	2021
33623038	Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.	Nat Commun	2021
33359587	Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma.	Journal of Allergy and Clinical Immunology: In Practice	2021
32800727	Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.	Eur Urol	2021
32853339	Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.	J Natl Cancer Inst	2021
33420416	Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.	Prostate Cancer Prostatic Dis	2021
33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
31350754	Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study.	Int J Cancer	2020
32183364	Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer.	Genes (Basel)	2020
31949111	Overuse of short-acting Î²-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.	European Respiratory Journal	2020
34337468	Identification and Validation of Leucine-rich Î±-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification.	Eur Urol Open Sci	2020
33149565	Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation.	International Journal of COPD	2020
32514134	The effect of sample size on polygenic hazard models for prostate cancer.	Eur J Hum Genet	2020
32620889	Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.	Nat Commun	2020
33158149	The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.	Cancers (Basel)	2020
31095758	Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden.	Allergy: European Journal of Allergy and Clinical Immunology	2019
30622367	Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Nat Genet	2019
30683880	Shared heritability and functional enrichment across six solid cancers.	Nat Commun	2019
31548585	Publisher Correction: Shared heritability and functional enrichment across six solid cancers.	Nat Commun	2019
29321194	Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.	BMJ	2018
28753803	The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing.	Eur Urol Focus	2018
28753802	Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.	Eur Urol Focus	2018
29892050	Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.	Nat Commun	2018
29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Nat Genet	2018
30397198	Germline variation at 8q24 and prostate cancer risk in men of European ancestry.	Nat Commun	2018
30157291	ANO7 is associated with aggressive prostate cancer.	Int J Cancer	2018
29878078	AA9int: SNP interaction pattern search using non-hierarchical additive model set.	Bioinformatics	2018
30181389	Synergistic Interaction of <i>HOXB13</i> and <i>CIP2A</i> Predisposes to Aggressive Prostate Cancer.	Clin Cancer Res	2018
29438364	Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.	Br J Cancer	2018
29438362	Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.	Br J Cancer	2018
29298992	Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.	Prostate Cancer Prostatic Dis	2018
28039167	SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns.	Bioinformatics	2017
28604732	Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor.	Nat Genet	2017
28604728	Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.	Nat Genet	2017
28765617	Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.	Br J Cancer	2017